JP2010529147A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529147A5
JP2010529147A5 JP2010511418A JP2010511418A JP2010529147A5 JP 2010529147 A5 JP2010529147 A5 JP 2010529147A5 JP 2010511418 A JP2010511418 A JP 2010511418A JP 2010511418 A JP2010511418 A JP 2010511418A JP 2010529147 A5 JP2010529147 A5 JP 2010529147A5
Authority
JP
Japan
Prior art keywords
compound
membered heterocycle
halogen
och
cho
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010511418A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010529147A (ja
JP4827986B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/066310 external-priority patent/WO2008154484A1/en
Publication of JP2010529147A publication Critical patent/JP2010529147A/ja
Publication of JP2010529147A5 publication Critical patent/JP2010529147A5/ja
Application granted granted Critical
Publication of JP4827986B2 publication Critical patent/JP4827986B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010511418A 2007-06-08 2008-06-09 IRE−1αインヒビター Expired - Fee Related JP4827986B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94274307P 2007-06-08 2007-06-08
US60/942,743 2007-06-08
PCT/US2008/066310 WO2008154484A1 (en) 2007-06-08 2008-06-09 Ire-1a inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011012200A Division JP5684585B2 (ja) 2007-06-08 2011-01-24 IRE−1αインヒビター

Publications (3)

Publication Number Publication Date
JP2010529147A JP2010529147A (ja) 2010-08-26
JP2010529147A5 true JP2010529147A5 (cg-RX-API-DMAC7.html) 2011-03-10
JP4827986B2 JP4827986B2 (ja) 2011-11-30

Family

ID=39730581

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2010511418A Expired - Fee Related JP4827986B2 (ja) 2007-06-08 2008-06-09 IRE−1αインヒビター
JP2011012200A Expired - Fee Related JP5684585B2 (ja) 2007-06-08 2011-01-24 IRE−1αインヒビター
JP2013169387A Ceased JP2014055129A (ja) 2007-06-08 2013-08-19 IRE−1αインヒビター
JP2015005455A Expired - Fee Related JP5941173B2 (ja) 2007-06-08 2015-01-15 IRE−1αインヒビター

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2011012200A Expired - Fee Related JP5684585B2 (ja) 2007-06-08 2011-01-24 IRE−1αインヒビター
JP2013169387A Ceased JP2014055129A (ja) 2007-06-08 2013-08-19 IRE−1αインヒビター
JP2015005455A Expired - Fee Related JP5941173B2 (ja) 2007-06-08 2015-01-15 IRE−1αインヒビター

Country Status (8)

Country Link
US (5) US7858666B2 (cg-RX-API-DMAC7.html)
EP (4) EP2520561B1 (cg-RX-API-DMAC7.html)
JP (4) JP4827986B2 (cg-RX-API-DMAC7.html)
CN (2) CN103450077B (cg-RX-API-DMAC7.html)
CA (2) CA2690913C (cg-RX-API-DMAC7.html)
ES (2) ES2569660T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009013332A (cg-RX-API-DMAC7.html)
WO (1) WO2008154484A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2520561B1 (en) * 2007-06-08 2016-02-10 MannKind Corporation IRE-1A Inhibitors
JP2013500265A (ja) * 2009-07-23 2013-01-07 ザ トラスティーズ オブ プリンストン ユニバーシティ 抗ウイルス剤として用いられるmTORキナーゼ阻害剤
CN102724975B (zh) * 2009-11-03 2015-12-02 满康德股份有限公司 IRE-1α抑制剂
CN110172051B (zh) 2010-04-05 2023-03-07 复星弘创(苏州)医药科技有限公司 IRE-1α抑制剂
TWI562977B (en) * 2010-11-05 2016-12-21 Bayer Ip Gmbh Process for the preparation of substituted n-(benzyl)cyclopropanamines by imine hydrogenation
US9956236B2 (en) 2011-02-07 2018-05-01 Cornell University Methods for increasing immune responses using agents that directly bind to and activate IRE-1
US9359299B2 (en) 2011-04-04 2016-06-07 Georgetown University Small molecules for treating breast cancer
RS55462B1 (sr) 2011-08-19 2017-04-28 Glaxo Group Ltd Jedinjenja benzofurana za tretiranje infekcija sa virusom hepatitisa c
US20150018406A1 (en) 2012-03-09 2015-01-15 Cornell University Modulation of breast cancer growth by modulation of xbp1 activity
EP2841449B1 (en) 2012-04-23 2016-12-28 IMBA-Institut für Molekulare Biotechnologie GmbH Archease as rna ligase complex member
KR20150061651A (ko) 2012-09-26 2015-06-04 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Ire1의 조절
ES2724300T3 (es) 2013-09-25 2019-09-10 Univ Cornell Compuestos para inducir inmunidad antitumoral y métodos de lo mismo
CN114380700A (zh) * 2013-10-08 2022-04-22 卢庆彬 用于靶向化疗的非铂基抗癌化合物
WO2015136887A1 (ja) * 2014-03-10 2015-09-17 国立大学法人広島大学 滑膜細胞増殖抑制剤及び滑膜細胞の増殖抑制方法
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US20160106687A1 (en) 2014-10-21 2016-04-21 Life Plus, LLC Human therapeutic agents
US20190388426A1 (en) 2017-01-30 2019-12-26 Université de Liège Perk and ire-1a inhibitors against neurodevelopmental disorders
CN106974908B (zh) * 2017-03-02 2019-11-12 深圳大学 含有hdac抑制剂和ire1抑制剂的药物组合物及用途
CN106822904B (zh) * 2017-03-08 2019-10-25 暨南大学 含akt抑制剂和ire1抑制剂的药物组合物及其应用
CN107308178B (zh) * 2017-07-31 2020-11-10 苏州大学附属儿童医院 一种用于肠外营养相关性肝病药物
BR112020019708A2 (pt) * 2018-03-27 2021-02-09 Neuropore Therapies, Inc. compostos como moduladores de sinalização de tlr2
JP2021529757A (ja) 2018-07-03 2021-11-04 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 小胞体ストレス応答の活性剤
WO2020019107A1 (en) * 2018-07-23 2020-01-30 Fosun Orinove Pharmatech, Inc. IRE1α INHIBITOR IN COMBINATION WITH CANCER THERAPEUTIC AGENT FOR CANCER TREATMENT
CN113164457A (zh) * 2018-07-23 2021-07-23 复星弘创(苏州)医药科技有限公司 IRE1α抑制剂与癌症治疗剂联合用于癌症治疗
AU2018447495A1 (en) * 2018-11-02 2021-06-17 Fosun Orinove Pharmatech, Inc. IRE1α inhibitor in combination with cancer therapeutic agent for cancer treatment
SG11202109936YA (en) * 2019-03-26 2021-10-28 Neuropore Therapies Inc Compounds and compositions as modulators of tlr signaling
US12129265B2 (en) 2020-07-21 2024-10-29 Ankh Life Sciences Limited Therapeutic agents and uses thereof
CN118576600A (zh) * 2024-05-31 2024-09-03 中山大学附属第三医院 IRE1α抑制剂KIRA8在制备治疗复发难治多发性骨髓瘤的药物中的应用

Family Cites Families (404)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE209910C (cg-RX-API-DMAC7.html)
US675543A (en) 1899-08-05 1901-06-04 Farbenfabriken Elberfeld Co Derivatives of aromatic oxy-aldehydes and process of making same.
US2346662A (en) * 1940-04-08 1944-04-18 Universal Oil Prod Co Suppression of metal catalysis
US2282907A (en) 1941-05-01 1942-05-12 Us Rubber Co Parasiticide
US2649444A (en) 1948-10-19 1953-08-18 Burroughs Wellcome Co Process for the preparation of amino ketones
US2778853A (en) 1952-09-10 1957-01-22 Merck & Co Inc Deamination process
US2771391A (en) 1953-08-20 1956-11-20 Allied Lab Inc Physiologically active p-alkoxy-beta-piperidinopropiophenones causing cns depressantand anesthetic effects in animals
US2712031A (en) * 1953-10-27 1955-06-28 Lasdon Foundation Inc Monosubstituted salicylaldehyde alkoximes
US3080372A (en) 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
CH402859A (de) 1960-05-24 1965-11-30 Wander Ag Dr A Verfahren zur Herstellung von a-Pyrrolidino-valerophenonen
US3252996A (en) 1962-10-02 1966-05-24 Ciba Geigy Corp Alpha-pyrrolidinomethyl valero and caprophenones
US3151124A (en) 1961-11-20 1964-09-29 Ciba Geigy Corp Alpha oxy-beta alkyl-gamma tertiary amino-alpha phenyl propanes
NL293782A (cg-RX-API-DMAC7.html) 1962-06-11
US3203962A (en) 1962-10-11 1965-08-31 Ciba Geigy Corp Alpha-phenyl-beta pyrrolidino-propiophenones
US3148997A (en) 1963-01-04 1964-09-15 Dow Chemical Co Catechol compounds in improving clays and clay-containing materials
US3211613A (en) 1963-01-14 1965-10-12 Merck & Co Inc Anticoccidial compositions and method of using same
FR1453234A (fr) 1964-02-18 1966-06-03 Pechiney Progil Sa Nouveaux composés fongicides à usage agricole
US3340300A (en) 1964-10-05 1967-09-05 American Cyanamid Co Trimethoxy benzoylacetaldehyde oximes
CH445193A (de) 1964-12-14 1967-10-15 Agripat Sa Fungizides Mittel und seine Verwendung
FR1437423A (fr) * 1964-12-29 1966-05-06 Pechiney Progil Sa Composés fongicides nouveaux à usage agricole dérivés de l'aldéhyde salicylique
US3816433A (en) 1965-03-24 1974-06-11 Ferrosan Ab 4-fluoro-ypsilon-(4-methylpiperidino)-butyrophenone and its pharmaceutically acceptable salts
US3325521A (en) 1965-07-19 1967-06-13 Parke Davis & Co Halogenated cresol compounds and methods for their production
US3417087A (en) 1965-12-27 1968-12-17 Research Corp 3(aminopropionyl)benzothiophenes
CH479246A (de) 1966-10-28 1969-10-15 Ciba Geigy Mittel zur Bekämpfung von phytopathogenen Pilzen und Bakterien
FR1588756A (cg-RX-API-DMAC7.html) 1967-05-26 1970-03-16 Pepro
DE1679900A1 (de) * 1967-09-07 1971-04-08 Agfa Gevaert Ag Verfahren zum Verkleben von Polyesterfilmen
US3681445A (en) 1968-01-19 1972-08-01 Merck & Co Inc Substituted phenyl benzoic acid compounds
DE1989548U (de) 1968-03-29 1968-07-18 Karl Muenkel K G Zwei- oder mehrteiliger badezimmerschrank aus kunststoff.
US3721741A (en) 1968-10-28 1973-03-20 Ciba Geigy Ag Combatting phytopathogenic fungi on plants with sub-phytoloxic fungicidally effective amounts of herbicidal n-phenyl derivatives of 3,5-dihalo-salicylaldehyde
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3651085A (en) 1969-04-14 1972-03-21 Robins Co Inc A H 1-(omega-benzoylalkyl)-3-substituted pyrrolidines
US3703527A (en) 1969-06-04 1972-11-21 Hoffmann La Roche Preparation of mannich-bases
DE2021470A1 (de) 1970-05-02 1971-11-25 Cassella Farbwerke Mainkur Ag Piperazinderivate
FR2092133B1 (cg-RX-API-DMAC7.html) 1970-05-06 1974-03-22 Orsymonde
US3714226A (en) 1970-06-09 1973-01-30 Merck & Co Inc Phenyl benzoic acid compounds
DE2142245C3 (de) * 1971-08-24 1980-09-04 Basf Ag, 6700 Ludwigshafen Farbstoffe auf der Basis von Imino-isoindolin, deren Herstellung und Verwendung als Pigmente für Lacke und zum Anfärben von Polyestermaterialien
US3969356A (en) 1971-09-13 1976-07-13 Kali-Chemie Aktiengesellschaft N-[3-(p-f-benzoyl)-propyl]-N'-[2.(nitro,nitro-el, or methoxyphenyl)-ethyl]-p
US3806526A (en) 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3962459A (en) 1973-09-04 1976-06-08 Sandoz, Inc. Lipidemia treatment with p-phenoxy-alkylphenone compositions
US3873539A (en) 1973-10-03 1975-03-25 Sandoz Ag Substituted-4-aminoacetyl alkanoylphenones
US3992546A (en) 1973-10-18 1976-11-16 Ciba-Geigy Corporation 4-Piperidinobutyrophenones as neuroleptics
US4054570A (en) 1973-10-18 1977-10-18 Ciba-Geigy Corporation 4-Piperidinobutyrophenones
US3944064A (en) 1973-10-26 1976-03-16 Alza Corporation Self-monitored device for releasing agent at functional rate
US3995047A (en) 1973-12-14 1976-11-30 Eisai Co., Ltd. Propiophenone derivatives in the treatment of pathological muscular conditions
US3912755A (en) 1974-01-30 1975-10-14 Lilly Co Eli Preparation of pharmaceutical intermediates
US3931197A (en) 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
IL48319A0 (en) 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
US4028366A (en) 1975-01-20 1977-06-07 Sterling Drug Inc. 2-Naphthyl-lower-alkanoylamines
US4169892A (en) 1975-04-03 1979-10-02 Innothera 1-(benzothien-2'-yl)-3-morpholino propanones and therapeutic compositions containing same
US4066788A (en) 1975-10-03 1978-01-03 Richardson-Merrell Inc. Substituted benzaldehyde hypolipidemic agents
DE2557341A1 (de) 1975-12-19 1977-06-30 Hoechst Ag Basisch substituierte indolderivate und verfahren zu ihrer herstellung
US4333941A (en) 1975-12-22 1982-06-08 The Dow Chemical Company Inhibition of enveloped viruses with phenyl ketones
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4015014A (en) 1976-03-17 1977-03-29 The Dow Chemical Company Method for the use of aryl azines as anthelmintics
DE2620254C2 (de) * 1976-05-07 1984-03-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Hydroxybenzaldehyden
IT1068110B (it) 1976-08-13 1985-03-21 Montedison Spa Processo per la preparazione di aldeidi 2 idrossibenzoiche
US4072852A (en) * 1976-08-23 1978-02-07 Honeywell Inc. Digital computer monitoring and restart circuit
US4072582A (en) 1976-12-27 1978-02-07 Columbia Chemical Corporation Aqueous acid plating bath and additives for producing bright electrodeposits of tin
US4183553A (en) * 1977-02-04 1980-01-15 Ciba-Geigy Corporation Pressure- or heat-sensitive recording material and novel chromano compounds used therein
DE2718405A1 (de) 1977-04-26 1978-11-02 Boehringer Sohn Ingelheim Neue n- eckige klammer auf 1-(3-benzoylpropyl)-4-piperidyl eckige klammer zu -sulfonsaeureamide und verfahren zu deren herstellung
US4176198A (en) 1977-10-06 1979-11-27 William H. Rorer, Inc. Method of treatment
US4311841A (en) * 1977-11-21 1982-01-19 Petrolite Corporation Process of preparing hexahydropyrimidines
JPS54110321A (en) 1978-02-20 1979-08-29 Ajinomoto Co Inc Insecticide
JPS54125630A (en) 1978-02-22 1979-09-29 Nippon Zoki Pharmaceutical Co Novel propanone derivative*its manufacture and medical composition containing it as active component
JPS54163538A (en) 1978-06-13 1979-12-26 Sumitomo Chemical Co Production of salycilaldehydes
US4230727A (en) 1979-04-02 1980-10-28 William H. Rorer, Inc. Compositions and method of treatment
JPS606339B2 (ja) 1979-04-28 1985-02-18 ダイキン工業株式会社 フツ素化方法
FR2475044A1 (fr) * 1980-02-04 1981-08-07 Anvar Derives de nitro-2 naphtofurannes, leur preparation et leur application notamment comme regulateurs de la croissance cellulaire
DE3019497A1 (de) 1980-05-22 1981-11-26 Bayer Ag, 5090 Leverkusen Aminopropiophenon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3019496A1 (de) 1980-05-22 1981-11-26 Bayer Ag, 5090 Leverkusen Aminopropanol-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
FR2486523A1 (fr) 1980-07-11 1982-01-15 Rhone Poulenc Ind Procede de preparation de polyphenols comportant eventuellement un groupement aldehyde
GB2080803B (en) * 1980-07-28 1984-01-18 Pfizer Hypoglycemic 5-substituted oxazolidine-2,4-diones
DE3101750A1 (de) 1981-01-21 1982-08-26 Basf Ag, 6700 Ludwigshafen Verfahren zur kontinuierlichen herstellung von ethanol
US4381308A (en) 1981-04-23 1983-04-26 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4507268A (en) * 1982-01-25 1985-03-26 Henkel Corporation Solvent extraction
JPS58181971A (ja) 1982-04-15 1983-10-24 松下電器産業株式会社 自動車用キ−レスエントリ装置
JPS5944371A (ja) 1982-09-07 1984-03-12 Dainippon Pharmaceut Co Ltd 1―フエニル―2―メチル―3―(1―ピロリジニル)―1―プロパノン誘導体
FR2534912B1 (fr) 1982-10-26 1985-06-28 Lafon Labor Nouveaux derives de (2,4,6-trimethoxyphenyl) - (3-piperidinopropyl) -cetone, utilisation en therapeutique et procede de preparation
DE3332780A1 (de) 1983-09-10 1985-03-28 Hoechst Ag, 6230 Frankfurt 6-sulfoxyphenolderivate, ihre herstellung und ihre verwendung als cytoprotekiva
US4686235A (en) 1983-10-12 1987-08-11 Merck & Co., Inc. Substituted cinnamyl-2,3-dihydrobenzofuran and analogs useful as anti-inflammatory agents
HU33131A (cg-RX-API-DMAC7.html) 1984-01-26 1984-10-29
US4544663A (en) 1984-05-07 1985-10-01 Sandoz, Inc. Indolamine derivatives as anti-fertility agents
DE3436450A1 (de) 1984-10-05 1986-04-10 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von p-aminoethylketonen
US5057535A (en) 1985-04-11 1991-10-15 Nippon Kayaku Kabushiki Kaisha Derivatives of an aminoketone
FR2584715B1 (fr) 1985-07-10 1987-10-09 Lafon Labor Phenyl-(3-hexamethyleneiminopropyl)-cetone, procede de preparation et utilisation en therapeutique
FR2597864B1 (fr) 1986-04-28 1990-11-16 Lafon Labor Nouveaux derives de la n-((trimethoxy-2,4,6-benzoyl)-3 propyl) piperidine, leurs procedes de preparation et leur application en therapeutique
US5571886A (en) 1986-12-23 1996-11-05 Shipley Company, Inc. Aromatic novolak resins
JPH0637389B2 (ja) 1986-12-26 1994-05-18 北陸製薬株式会社 頻尿治療剤
JPS63243085A (ja) * 1987-03-30 1988-10-07 Toray Ind Inc 新規スピロナフトピラン化合物
FR2618145B1 (fr) 1987-07-17 1989-11-24 Rhone Poulenc Chimie Procede de chloration selective de composes phenoliques
US4847429A (en) 1987-08-03 1989-07-11 Eastman Kodak Company Synthesis of phenylhydroquinones
US4927956A (en) 1987-09-16 1990-05-22 Hoechst Celanese Corporation 3,5-disubstituted-4-acetoxystyrene and process for its production
US5025036A (en) 1987-10-01 1991-06-18 Hoffmann-La Roche Inc. Catechol carboxylic acids
JPH0256469A (ja) * 1987-12-08 1990-02-26 Kumiai Chem Ind Co Ltd ピリミジン誘導体及び除草剤
JPH02264946A (ja) 1989-04-05 1990-10-29 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
JPH085780B2 (ja) 1989-04-28 1996-01-24 呉羽化学工業株式会社 変形性関節症治療剤
EP0435827A3 (en) 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
DE4012008A1 (de) 1990-04-13 1991-10-17 Bayer Ag Verfahren zur herstellung von o-hydroxy-benzaldehyden
US5025006A (en) 1990-06-26 1991-06-18 Merck & Co., Inc. 2-biphenyl-carbapenem antibacterial agents
EP0467434A1 (en) 1990-06-26 1992-01-22 Merck & Co. Inc. 2-Biphenyl-carbapenem antibacterial agents
EP0464900A3 (en) 1990-06-26 1992-07-22 Merck & Co. Inc. 2-biphenyl-carbapenems
US5202355A (en) 1991-06-12 1993-04-13 Takasago Institute For Interdisciplinary Science Inc. Method of inhibiting aldose reductase in diabetic hosts using phenol derivatives
GB9119920D0 (en) 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
JPH05127335A (ja) 1991-10-14 1993-05-25 Fuji Photo Film Co Ltd 熱現像拡散転写型カラー感光材料
JPH05127330A (ja) 1991-11-06 1993-05-25 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料の処理方法
JPH05255089A (ja) 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
GB9127279D0 (en) 1991-12-23 1992-02-19 Ici Plc Heterocyclic derivatives
FR2689505B1 (fr) 1992-04-03 1995-06-09 Rhone Poulenc Chimie Procede d'hydroxylation de composes phenoliques.
AU3901393A (en) 1992-04-10 1993-11-18 Zeneca Limited Biphenylylquinuclidine derivatives as squalene synthase inhibitors
US5198422A (en) 1992-06-11 1993-03-30 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
GB9217723D0 (en) 1992-08-20 1992-09-30 Ici Plc Chemical process
JPH06135153A (ja) 1992-10-29 1994-05-17 Fuji Photo Film Co Ltd 感熱記録材料
FR2698353B1 (fr) 1992-11-25 1995-02-17 Rhone Poulenc Chimie Procédé de O-alkylation des composés phénoliques.
WO1994020473A1 (fr) 1993-03-11 1994-09-15 Yamanouchi Pharmaceutical Co., Ltd. Compose avec action antagoniste de la vasopressine
GB2276162A (en) 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benazilide derivatives
KR100238346B1 (ko) 1993-04-07 2000-03-02 오쓰까 아끼히꼬 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제
GB9307527D0 (en) 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
GB9308652D0 (en) 1993-04-27 1993-06-09 Wellcome Found Anti-inflammatory compounds
JPH06332264A (ja) 1993-05-24 1994-12-02 Hodogaya Chem Co Ltd 静電荷像現像用トナー
JPH0784415A (ja) 1993-06-25 1995-03-31 Hodogaya Chem Co Ltd 正帯電性トナー用摩擦帯電付与部材
DK77393D0 (da) 1993-06-29 1993-06-29 Novo Nordisk As Aktivering af enzymer
IL110159A0 (en) 1993-06-30 1994-10-07 Wellcome Found Diaryl compounds, their preparation and pharmaceutical compositions containing them
IT1266582B1 (it) 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
EP0714389B1 (en) 1993-08-20 1998-06-17 Smithkline Beecham Plc Amide and urea derivatives as 5ht1d receptor antagonists
IS4208A (is) * 1993-09-22 1995-03-23 Glaxo Group Limited 3-(tetrazólýl-benzyl)amínó-piperadidín afleiður
US5420362A (en) 1993-10-08 1995-05-30 Clairol, Inc. Synthesis of 2-methyl-1-naphthol
JPH09506101A (ja) 1993-12-07 1997-06-17 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5ht1d拮抗薬として有用な複素環式ビフェニリルアミド類
EP0886183A1 (en) 1993-12-17 1998-12-23 Fuji Photo Film Co., Ltd. Positive-working photoresist composition
GB9326008D0 (en) 1993-12-21 1994-02-23 Smithkline Beecham Plc Novel compounds
EP0736023B1 (en) 1993-12-21 1998-07-08 Smithkline Beecham Plc Indole, indoline and quinoline derivatives with 5ht 1d (anti-depressive) activity
US5654260A (en) 1994-01-10 1997-08-05 Phillips Petroleum Company Corrosion inhibitor for wellbore applications
US5565416A (en) 1994-01-10 1996-10-15 Phillips Petroleum Company Corrosion inhibitor for wellbore applications
AU1843295A (en) 1994-02-23 1995-09-11 Chiron Corporation Method and compositions for increasing the serum half-life of pharmacologically active agents
ES2122564T3 (es) 1994-03-26 1998-12-16 Smithkline Beecham Plc Derivados de bifenilo como antagonistas del receptor 5ht1d.
GB9408577D0 (en) 1994-04-29 1994-06-22 Fujisawa Pharmaceutical Co New compound
WO1995030675A1 (en) 1994-05-06 1995-11-16 Smithkline Beecham Plc Biphenylcarboxamides useful as 5-ht1d antagonists
JPH10500960A (ja) 1994-05-28 1998-01-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5ht1d−アンタゴニスト活性を有するアミド誘導体
US20010020100A1 (en) 1994-06-14 2001-09-06 G.D. Searle & Co. N-substituted-1, 2, 4-triazolone compounds for treatment of cardiovascular disorders
DE4423061C1 (de) 1994-07-01 1996-01-18 Hoechst Ag Verfahren zur Herstellung von Biphenylen mit Palladacyclen als Katalysatoren
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5579110A (en) 1994-08-31 1996-11-26 Honeywell Inc. In-line multiple rotation sensor assembly
CA2158191A1 (en) 1994-09-16 1996-03-17 Junji Yokoi Method for preventing settlement of aquatic fouling organisms
US5599974A (en) 1994-09-19 1997-02-04 Center For Innovative Technology Aldehydic agents for allosteric modification of hemoglobin
US5593994A (en) 1994-09-29 1997-01-14 The Dupont Merck Pharmaceutical Company Prostaglandin synthase inhibitors
GB9421003D0 (en) 1994-10-18 1994-12-07 Smithkline Beecham Plc Novel compounds
US6214994B1 (en) 1997-04-21 2001-04-10 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1′-yl propanones
US5705501A (en) 1994-11-17 1998-01-06 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's Disease
DE4444244A1 (de) 1994-12-13 1996-06-20 Basf Ag Photochrome Spiroindoline
AU697361B2 (en) 1994-12-22 1998-10-01 Smithkline Beecham Plc Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists
EP0802912B1 (en) 1995-01-12 2004-10-13 Glaxo Group Limited Piperidine derivatives having tachykinin antagonist activity
BR9607016A (pt) 1995-02-02 1997-10-28 Smithkline Beecham Plc Derivados de indol como antagonísta de receptor 5-ht
EP0817767B1 (en) 1995-03-27 2000-05-24 Smithkline Beecham Plc Bicyclic amine derivatives and their use as anti-psychotic agents
CN1130355C (zh) 1995-04-04 2003-12-10 德州生物科技公司 调理内皮肽活性的噻吩基-、呋喃基-、吡咯基-与联苯磺酰胺及其衍生物
GB9507203D0 (en) 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
GB9508637D0 (en) 1995-04-28 1995-06-14 Fujisawa Pharmaceutical Co New use
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
GB9512697D0 (en) 1995-06-22 1995-08-23 Zeneca Ltd Heterocyclic compounds
EP0783502A1 (en) 1995-08-02 1997-07-16 J. URIACH & CIA. S.A. New carboxamides with antifungal activity
GB9519033D0 (en) 1995-09-18 1995-11-15 Smithkline Beecham Plc Treatment
FR2739098B1 (fr) 1995-09-25 1997-11-28 Rhone Poulenc Chimie Procede d'acylation d'un compose aromatique
GB9522845D0 (en) 1995-11-08 1996-01-10 Smithkline Beecham Plc Novel compounds
EP0862565A1 (en) 1995-11-22 1998-09-09 Smithkline Beecham Plc Tricyclic spiro compounds as 5ht 1d? receptor antagonists
US5763496A (en) 1995-11-27 1998-06-09 The Research Foundation Of State University Of New York Prevention of atherosclerosis using NADPH oxidase inhibitors
JPH09149797A (ja) 1995-11-30 1997-06-10 Internatl Reagents Corp 酵素、抗原又は抗体の定量方法及び酵素活性測定用の基質
US5977105A (en) 1995-12-06 1999-11-02 Astra Pharmaeuticals Ltd. Compounds
FR2744720B1 (fr) 1996-02-09 1998-04-10 Rhone Poulenc Chimie Procede d'hydroxylation de composes phenoliques
FR2745287B1 (fr) 1996-02-28 1998-04-10 Rhone Poulenc Chimie Nouvelle composition catalytique et sa mise en oeuvre dans un procede d'acylation d'un compose aromatique
FR2745285B1 (fr) 1996-02-28 1998-04-10 Rhone Poulenc Chimie Nouveau catalyseur de c-alkylation d'un compose aromatique et son utilisation
GB9605945D0 (en) 1996-03-21 1996-05-22 Smithkline Beecham Plc Novel compounds
GB9606370D0 (en) 1996-03-26 1996-06-05 Dormer Tools Sheffield Ltd Improvements in or relating to twist drills
GB9606396D0 (en) 1996-03-27 1996-06-05 Smithkline Beecham Plc Novel compounds
JP2000507253A (ja) 1996-03-27 2000-06-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー アザスピロ誘導体
GB9607219D0 (en) 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
EP0845026A1 (de) 1996-06-19 1998-06-03 CALL, Hans-Peter Dr. Mehrkomponentensystem zur verwendung mit waschaktiven substanzen
US6462064B1 (en) 1996-07-08 2002-10-08 Galderma Research & Development S.N.C. Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
ES2231877T3 (es) 1996-07-08 2005-05-16 GALDERMA RESEARCH & DEVELOPMENT, S.N.C. Derivados de adamantillo inductores de apoptosis y su utilizacion como agentes anticancerigenos.
KR100338855B1 (ko) 1996-07-31 2002-12-28 시오노기세이야쿠가부시키가이샤 신규 파라테르페닐 화합물
DE19631131A1 (de) 1996-08-01 1998-02-05 Consortium Elektrochem Ind Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
JP3202607B2 (ja) * 1996-08-01 2001-08-27 帝人株式会社 2−(4−アルコキシ−3−シアノフェニル)チアゾール誘導体の製造法
FR2752165B1 (fr) * 1996-08-12 1998-10-09 Intertechnique Sa Equipement de protection respiratoire a mise en place rapide
US5668182A (en) 1996-08-19 1997-09-16 Virginia Commonwealth University Method of calming or sedating an animal with a hydroxy benzaldehyde compound
EP0932600B1 (en) 1996-10-11 2006-02-08 Warner-Lambert Company Llc Sulfonamide substituted aspartic acid interleukin-1beta converting enzyme inhibitors
FR2754533B1 (fr) 1996-10-14 1998-11-27 Rhodia Chimie Sa Procede de preparation selective d'un acide 2-hydroxybenzoique et d'un 4-hydroxybenzaldehyde et derives
FR2756278B1 (fr) 1996-11-22 1998-12-31 Rhodia Chimie Sa Procede de preparation d'un 4-hydroxybenzaldehyde et derives
FR2756279B1 (fr) 1996-11-27 1999-01-22 Rhodia Chimie Sa Procede d'acylation d'un compose aromatique
US6005009A (en) 1997-03-19 1999-12-21 Duke University Method of inhibiting fibrosis with pyridoxal benzoyl hydrazone and analogs thereof
FR2761687B1 (fr) * 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
NZ500590A (en) 1997-04-22 2001-11-30 Cocensys Inc Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
US6288276B1 (en) 1997-05-21 2001-09-11 Henkel Kommanditgeselschaft Auf Aktien Salicylaldoximes and method of preparation
US6013841A (en) 1997-07-17 2000-01-11 Dakota Gasification Company Method for the conversion of 3- and 4-methylcatechol to benzaldehyde
FR2768729A1 (fr) 1997-09-19 1999-03-26 Rhodia Chimie Sa Procede d'acylation d'un compose aromatique et complexes catalytiques
FR2768728B1 (fr) 1997-09-19 1999-12-03 Rhodia Chimie Sa Procede d'acylation d'un compose aromatique
US6174656B1 (en) 1997-09-30 2001-01-16 Fuji Photo Film Co., Ltd. Silver halide photographic light-sensitive material, aromatic aldehyde derivative compound, and image-forming method
US6124507A (en) 1997-12-10 2000-09-26 Union Carbide Chemicals & Plastics Technology Corporation Electron donors
CA2315397C (en) 1997-12-19 2007-08-07 Merck & Co., Inc. Arylthiazolidinedione derivatives
EP0938025A1 (en) 1998-02-20 1999-08-25 Fuji Photo Film Co., Ltd. Heat developable color photographic light-sensitive material
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6340685B1 (en) 1998-05-22 2002-01-22 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6265395B1 (en) 1998-06-25 2001-07-24 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
YU78600A (sh) 1998-06-26 2002-11-15 Pfizer Products Inc. Poboljšani postupak dobijanja adukta schiff-ove baze amina sa 0-hidroksi aldehidima i na njima baziranih formulacija materijala
ES2257864T3 (es) 1998-07-10 2006-08-01 Massachusetts Institute Of Technology Ligandos para metales y procesos mejorados catalizados por metales basados en los mismos.
US6307087B1 (en) 1998-07-10 2001-10-23 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
JP2000026438A (ja) 1998-07-14 2000-01-25 Fujimoto Brothers:Kk 新規な2−(n−シアノイミノ)チアゾリジン−4− オン誘導体
JP4748338B2 (ja) 1998-09-11 2011-08-17 味の素株式会社 ベンゼン誘導体及びその医薬用途
US6521641B1 (en) 1998-10-08 2003-02-18 Allergan, Inc. Male anti-fertility agents
AU757448B2 (en) 1998-10-08 2003-02-20 Allergan, Inc. Male anti-fertility agents
DE19846514A1 (de) 1998-10-09 2000-04-20 Bayer Ag Neue Heterocyclyl-methyl-substituierte Pyrazole
AU3033500A (en) 1999-01-15 2000-08-01 Agouron Pharmaceuticals, Inc. Non-peptide glp-1 agonists
AUPP873799A0 (en) 1999-02-17 1999-03-11 Fujisawa Pharmaceutical Co., Ltd. Pyridine compounds
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
IT1306129B1 (it) 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
US6251927B1 (en) 1999-04-20 2001-06-26 Medinox, Inc. Methods for treatment of sickle cell anemia
ATE368023T1 (de) 1999-05-20 2007-08-15 Ciba Sc Holding Ag Hydroxydiphenyletherverbindungen
CN1202095C (zh) 1999-07-15 2005-05-18 住友制药株式会社 杂芳环化合物
WO2001007031A1 (en) 1999-07-26 2001-02-01 Shionogi & Co., Ltd. Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
WO2001014314A1 (en) 1999-08-20 2001-03-01 Nippon Kayaku Kabushiki Kaisha Benzene derivatives having aromatic substituents and processes for the preparation thereof
US6486342B1 (en) 1999-08-24 2002-11-26 Virginia Commonwealth University Substituted chiral allosteric hemoglobin modifiers
UA74344C2 (uk) 1999-08-31 2005-12-15 Максіа Фармасьютікалз, Інк. Бензилідентіазолідиндіони і їх аналоги та їх застосування для лікування діабету
DE19942700C1 (de) 1999-09-07 2001-04-05 Consortium Elektrochem Ind Verfahren zur Herstellung cyclischer N-Hydroxydicarboximide
YU21602A (sh) 1999-10-13 2005-06-10 Pfizer Products Inc. Derivati biaril etra korisni kao inhibitori ponovnog podizanja monoamina
PT1142885E (pt) 1999-11-12 2007-02-28 Fujimoto Brothers Co Ltd Derivados de 2-(n-cianoimino)tiazolidin-4-ona
US6329129B1 (en) 1999-11-25 2001-12-11 Fuji Photo Film Co., Ltd. Heat-developable color light-sensitive material
JP2001215669A (ja) 1999-11-25 2001-08-10 Fuji Photo Film Co Ltd 熱現像カラー感光材料
KR20010074549A (ko) 2000-01-25 2001-08-04 고사이 아끼오 키랄 구리 착물, 이의 제조 방법 및 이를 이용한 비대칭합성
EP1253128A4 (en) 2000-02-04 2004-06-23 Nihon Nohyaku Co Ltd PERFLUOROISOPROPYLBENZOL DERIVATIVES
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP2001316294A (ja) 2000-03-14 2001-11-13 Pfizer Prod Inc o−バニリンおよびo−バニリン/テトラメチルクロマニルカルボン酸化合物の組み合わせの使用法
WO2001074762A2 (en) * 2000-04-03 2001-10-11 Phycogen, Inc. Arylsulfates and their use as enhancers or inhibitors of bioadhesion to surfaces
ES2287120T3 (es) 2000-04-28 2007-12-16 Asahi Kasei Pharma Corporation Nuevos compuestos biciclicos.
JP2001335476A (ja) 2000-05-29 2001-12-04 Shionogi & Co Ltd 三環化合物の新規用途
AR029686A1 (es) 2000-06-22 2003-07-10 Dow Agrosciences Llc Compuestos de 2-(3,5-disustituido-4-piridil)-4-(tienilo, tiazolilo o arilfenil)-1,3-oxazolina, composiciones y metodos para el control de insectos o acaros y/o plantas utilizando dichos compuestos
EP1366030A2 (en) 2000-07-06 2003-12-03 Neurogen Corporation Melanin concentrating hormone receptor ligands
DE10038639A1 (de) 2000-07-28 2002-02-21 Schering Ag Nichtsteroidale Entzündungshemmer
EP1178036A1 (en) 2000-08-04 2002-02-06 Aventis Cropscience S.A. Fungicidal phenylimidate derivatives
GB0019359D0 (en) 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel guanidines
DE10040051A1 (de) 2000-08-11 2002-02-21 Basf Ag Derivate des 4-(Trifluormethyl)-phenols sowie Derivate des 4-(Trifluormethylphenyl)-2-(tetrahydropyranyl)ethers und Verfahren zu ihre Herstellung
DE10046272A1 (de) 2000-09-19 2002-03-28 Merck Patent Gmbh Aminoheterocyclen (Faktor Xa Inhibitoren 14)
DE10047111A1 (de) 2000-09-22 2002-04-11 Bayer Ag Verfahren zur Herstellung von DELTA·1·-Pyrrolinen
DE10047109A1 (de) 2000-09-22 2002-04-11 Bayer Ag Verfahren zur Herstellung von DELTA·1·-Pyrrolinen
ATE367815T1 (de) 2000-10-04 2007-08-15 Astellas Pharma Inc Verwendung von einem vasopressin-antagonisten wie conivaptan zur herstellung eines medikaments für die behandlung der pulmonalen hypertension
EP1339458B1 (en) 2000-11-22 2007-08-15 Novartis AG Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
AU2002223966A1 (en) 2000-12-20 2002-07-01 Warner Lambert Company Non-halogenated naphthol compounds and antimicrobial compositions containing the same
JP2002275165A (ja) 2001-01-12 2002-09-25 Sumitomo Pharmaceut Co Ltd トリアゾール誘導体
US20040147557A1 (en) 2001-01-15 2004-07-29 Anne Bouillot Aryl piperidine derivatives as inducers of ldl-receptor expression
DE10102341A1 (de) 2001-01-19 2002-08-08 Ralf Steffens Profilkontur einer Schraubenspindelpumpe
JP2004525118A (ja) * 2001-01-22 2004-08-19 アルパイダ アーゲー 新規ヒドラゾン類
MXPA01013326A (es) 2001-02-14 2002-08-26 Warner Lambert Co Bifenil sulfonamidas utiles como inhibisdores de metaloproteinasa de matriz.
US20030022923A1 (en) 2001-03-01 2003-01-30 Medinox, Inc. Methods for treatment of sickle cell anemia
CA2473156A1 (en) 2001-03-08 2002-09-19 Incyte San Diego, Inc. Rxr activating molecules
US6936590B2 (en) 2001-03-13 2005-08-30 Bristol Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
WO2002081442A2 (de) 2001-04-09 2002-10-17 Bayer Cropscience Ag Verfahren zum herstellen von δ1-pyrrolinen
PE20021081A1 (es) 2001-04-12 2002-12-18 Pharmacopeia Drug Discovery Aril y biaril piperidinas con actividad moduladora mch
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7326700B2 (en) 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US20020193403A1 (en) 2001-05-03 2002-12-19 Allergan Sales, Inc. Methods of treating hyperlipidemia
US20030187007A1 (en) 2001-05-30 2003-10-02 Cao Sheldon Xiaodong Inhibitors of protein kinase for the treatment of disease
DE60228447D1 (de) 2001-06-28 2008-10-02 Pfizer Prod Inc Triamidsubstituierte indole, benzofurane und benzothiophene als inhibitoren des mikrosomalen triglyceridtransferproteins (mtp) und/oder der sekretion von apolipoprotein b (apo b)
GB0119172D0 (en) 2001-08-06 2001-09-26 Melacure Therapeutics Ab Phenyl pyrrole derivatives
US6605620B1 (en) 2001-08-30 2003-08-12 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
US6867221B2 (en) 2001-08-30 2005-03-15 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
US20040235877A1 (en) 2001-09-14 2004-11-25 Natsuki Ishizuka Novel use of tricyclic compound
EP1429759A4 (en) 2001-09-26 2004-12-15 Bristol Myers Squibb Co COMPOUNDS FOR TREATING HEPATITIS C VIRUS
CN1561337A (zh) 2001-10-05 2005-01-05 惠氏公司 2-基苯并二氢吡喃衍生物的立体有择合成方法
DE10150335A1 (de) 2001-10-15 2003-04-24 Degussa Neue chirale Liganden und deren Übergangsmetallkomplexe sowie deren katalytische Anwendung
JP4581321B2 (ja) 2001-10-23 2010-11-17 住友化学株式会社 不飽和有機化合物誘導体の製造方法
US20060287337A1 (en) 2001-11-09 2006-12-21 Proteologics, Inc. Trans-golgi network-associated processes, methods and compositions related thereto
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
US20030157154A1 (en) 2002-01-04 2003-08-21 Bryan Fuller Compositions containing hydroxy aromatic aldehydes and their use in treatments
US6835745B2 (en) 2002-01-15 2004-12-28 Wyeth Phenyl substituted thiophenes as estrogenic agents
JP2003229174A (ja) * 2002-01-31 2003-08-15 Sanyo Electric Co Ltd フィルム状外装体を用いた非水電解質二次電池
EP1476419B1 (en) 2002-02-08 2006-02-01 Merck & Co., Inc. N-biphenylmethyl aminocycloalkanecarboxamide derivatives
TWI259079B (en) 2002-02-08 2006-08-01 Merck & Co Inc N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives
NZ535603A (en) 2002-03-20 2007-10-26 Metabolex Inc Substituted phenylacetic acids
EP1496896A4 (en) 2002-04-08 2007-10-31 Merck & Co Inc AKT INHIBITORS EFFECT
CA2480880C (en) 2002-04-08 2011-03-22 Merck & Co., Inc. Inhibitors of akt activity
MY134200A (en) 2002-04-12 2007-11-30 Kowa Co Method for treating cancer
DE10216368A1 (de) 2002-04-12 2003-10-16 Henkel Kgaa Arylsulfatase-Inhibitoren in Deodorantien und Antitranspirantien
US20030229149A1 (en) 2002-05-28 2003-12-11 Werner Baschong Anti-inflammatory agents
GB0216233D0 (en) 2002-07-12 2002-08-21 Glaxo Group Ltd Compounds
GB0216224D0 (en) 2002-07-12 2002-08-21 Glaxo Group Ltd Compounds
GB0216252D0 (en) 2002-07-12 2002-08-21 Glaxo Group Ltd Compounds
US20040044041A1 (en) 2002-08-06 2004-03-04 Kuduk Scott D. 2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives
US20040034064A1 (en) 2002-08-06 2004-02-19 Kuduk Scott D. 2-(biarylalkyl)amino-3-(alkanoylamino)pyridine derivatives
US20040063761A1 (en) 2002-08-06 2004-04-01 Kuduk Scott D. 2-(biarylalkyl)amino-3-(fluoroalkanoylamino)pyridine derivatives
SE0202692D0 (sv) 2002-09-11 2002-09-11 Astrazeneca Ab Compounds
WO2004037816A1 (en) * 2002-10-28 2004-05-06 Chugai Seiyaku Kabushiki Kaisha Benzofuran compounds having antitumor activity
WO2004050637A2 (en) * 2002-12-03 2004-06-17 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
WO2004052488A2 (en) 2002-12-03 2004-06-24 Bristol-Myers Squibb Company Process for removing metals from liquids
US6894061B2 (en) 2002-12-04 2005-05-17 Wyeth Substituted dihydrophenanthridinesulfonamides
PT2179987E (pt) 2002-12-04 2013-03-11 Univ Virginia Commonwealth Utilização de derivados carbaldeído heterocíclicos contra a anemia falciforme
EP1568691A4 (en) 2002-12-06 2010-08-25 Kowa Co ACCELERATOR FOR ERYTHROPOETIN PRODUCTION
DE10257357A1 (de) 2002-12-09 2004-06-24 Bayer Ag Fluorhaltige Benzaldehyde
WO2004056727A2 (en) 2002-12-19 2004-07-08 Atherogenics, Inc. Process of making chalcone derivatives
JP2006516979A (ja) * 2003-02-05 2006-07-13 ニューサウス イノベーションズ ピーティーワイ リミテッド 金属イオンキレート化剤およびその治療的使用
JP4331954B2 (ja) 2003-02-13 2009-09-16 株式会社リコー ユニット支持装置および画像形成装置
KR20050109513A (ko) 2003-02-28 2005-11-21 시바 스페셜티 케미칼스 홀딩 인크. 전기발광 장치
MY142651A (en) 2003-03-18 2010-12-15 Merck Sharp & Dohme Biaryl substituted triazoles as sodium channel blockers
CN101468965A (zh) 2003-03-24 2009-07-01 默克公司 联芳基取代的6元杂环钠通道阻滞剂
US20070043512A1 (en) 2003-03-26 2007-02-22 Michael Rolph Therapeutic and prophylactic compositions and uses therefor
JP2006522130A (ja) 2003-04-03 2006-09-28 メルク エンド カムパニー インコーポレーテッド ナトリウムチャンネル遮断薬としてのビアリール置換ピラゾール
WO2004094379A2 (en) 2003-04-16 2004-11-04 Amgen Inc. 3-phenyl-4- (pyrimidin-2-yl) -6- (piperidin-4-yl) derivatives and related compounds as tnf-alpha and il-1 inhibitors for the treatment of inflammations
CA2522476A1 (en) 2003-04-18 2004-11-04 Merck & Co., Inc. Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
US20040223912A1 (en) 2003-05-07 2004-11-11 Montalto Michael Christopher Compositions and methods for non-invasive imaging of soluble beta-amyloid
WO2004100998A2 (en) 2003-05-07 2004-11-25 General Electric Company Compositions and methods for non-invasive imaging of soluble beta-amyloid
DK1638544T3 (da) 2003-05-07 2008-03-31 Univ Aberdeen Ketoner og reducerede ketoner som terapeutiske midler til behandling af knogletilstande
GB0312654D0 (en) 2003-06-03 2003-07-09 Glaxo Group Ltd Therapeutically useful compounds
FR2857010B1 (fr) 2003-07-01 2005-09-16 Servier Lab Nouveaux derives bicycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2005009993A1 (en) 2003-07-15 2005-02-03 Smithkline Beecham Corporation Novel compounds
DK1651232T3 (da) 2003-07-23 2011-02-28 Synta Pharmaceuticals Corp Forbindelser mod inflammation og immunrelaterede anvendelser
JP4622857B2 (ja) 2003-07-25 2011-02-02 トヨタ自動車株式会社 ガス供給装置
JP2007528362A (ja) 2003-08-14 2007-10-11 旭化成ファーマ株式会社 置換アリールアルカン酸誘導体及びその用途
JP2007504199A (ja) 2003-09-05 2007-03-01 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド エレクトロルミネセンス素子
GB0321538D0 (en) 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
EP1674100A4 (en) 2003-10-10 2010-04-14 Kowa Co ANGIOGENESIS INHIBITORS
US6990935B2 (en) 2003-10-27 2006-01-31 Borgwarner Inc. Pivoting lifter control system using spool valve and check valve to recirculate oil
WO2005042498A2 (en) 2003-10-31 2005-05-12 Neurogen Corporation 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
AR046698A1 (es) 2003-11-11 2005-12-21 Ishihara Sangyo Kaisha Derivado bifenilo o su sal, y pesticida que lo contienen como un ingrediente activo
DE602004005071T2 (de) 2003-11-26 2007-11-08 Ciba Speciality Chemicals Holding Inc. Elektrolumineszente bauelemente
US7119208B2 (en) 2003-12-03 2006-10-10 Virginia Commonwealth University Anti-sickling agents
WO2005063222A1 (ja) 2003-12-26 2005-07-14 Kyowa Hakko Kogyo Co., Ltd. Hsp90ファミリー蛋白質阻害剤
US20050165025A1 (en) 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
US7501510B2 (en) 2004-03-26 2009-03-10 The University Of Hong Kong Thiourea compositions and uses thereof
FR2868417B1 (fr) 2004-04-02 2006-06-23 Rhodia Chimie Sa Procede de formation d'une liaison carbone-carbone
JP2006151946A (ja) 2004-04-30 2006-06-15 Konishi Kagaku Ind Co Ltd ジアリール誘導体の製造方法
GB0412874D0 (en) 2004-06-09 2004-07-14 Pfizer Ltd Novel pharmaceuticals
CN1968922A (zh) 2004-06-18 2007-05-23 米伦纽姆医药公司 因子xa抑制剂
DOP2005000123A (es) 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
DE102004035322A1 (de) 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
FR2874611B1 (fr) 2004-08-31 2006-11-17 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2008513364A (ja) * 2004-09-14 2008-05-01 ザ ジェネティクス カンパニー,インコーポレイテッド ヒドラゾン誘導体およびβ−セクレターゼインヒビターとしてのその使用
JP2008518937A (ja) 2004-10-28 2008-06-05 ジ インスティチューツ フォー ファーマシューティカル ディスカバリー、エルエルシー 置換カルボン酸
JP2006135153A (ja) 2004-11-08 2006-05-25 Canon Inc ビルドアッププリント配線基板および電子部品との接合構造
CA2590586A1 (en) 2004-12-13 2006-07-06 Neurogen Corporation Substituted biaryl analogues
WO2006074919A2 (de) 2005-01-12 2006-07-20 Curacyte Discovery Gmbh 3 -AMINO- 6-ARYL (BZW.6-HETEROARYL) -THIENO [2 , 3-B] PYRIDIN-2-CARBONSÄUREAMIDE, DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN UND IHRE VERWENDUNG ALS INHIBITOREN DER TNFα-FREISETZUNG
JP3839454B2 (ja) 2005-02-07 2006-11-01 三菱電機株式会社 内燃機関の制御装置
WO2006082245A1 (en) * 2005-02-07 2006-08-10 Novo Nordisk A/S Pharmaceutical preparations comprising insulin, zinc ions and a zinc-binding ligand
US9215874B2 (en) 2005-02-11 2015-12-22 Thomas Wegmann Fungicidal composition comprising a pyridylmethylbenzamide derivative and a thiazolecarboxamide derivative
US20060194821A1 (en) * 2005-02-18 2006-08-31 The Brigham And Women's Hospital, Inc. Compounds inhibiting the aggregation of superoxide dismutase-1
US7691848B2 (en) 2005-03-02 2010-04-06 Wyeth Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists
JP5159303B2 (ja) 2005-03-03 2013-03-06 武田薬品工業株式会社 放出制御組成物
US9271963B2 (en) 2005-03-03 2016-03-01 Universitat Des Saarlandes Selective inhibitors of human corticosteroid synthases
DE102005009705A1 (de) 2005-03-03 2006-09-07 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
TW200702363A (en) 2005-04-05 2007-01-16 Sumitomo Chemical Co Crosslinked polymer electrolyte and method for producing the same
US7482027B2 (en) 2005-04-30 2009-01-27 Angiolab, Inc. Composition for the prevention or treatment of diseases associated with angiogenesis
WO2006122186A2 (en) 2005-05-10 2006-11-16 Microbia, Inc. 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
US7687623B2 (en) 2005-05-12 2010-03-30 Wyeth Llc Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists
JP2008540564A (ja) 2005-05-12 2008-11-20 ワイス 卵胞刺激ホルモン受容体(fsh−r)アンタゴニストとしてのピロロベンゾジアゼピン、ヘテロアリール、アリールおよびシクロアルキルアミノケトン誘導体
WO2006124780A2 (en) 2005-05-12 2006-11-23 Kalypsys, Inc. Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
WO2006124748A2 (en) 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Multicyclic compounds and methods of their use
WO2006124897A2 (en) 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
US7705002B2 (en) 2005-05-19 2010-04-27 Vertex Pharmaceuticals Incorporated Biaryls useful as modulators of ion channels
CN101208342A (zh) 2005-06-09 2008-06-25 惠氏公司 作为促卵泡激素受体拮抗剂的吡咯并苯并二氮杂䓬吡啶羧酰胺和衍生物
ATE499372T1 (de) 2005-07-29 2011-03-15 Hoffmann La Roche Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
EP1923388A4 (en) 2005-08-12 2011-03-09 Takeda Pharmaceutical BRAIN / NEURONAL CELL PROTECTIVE AGENT AND THERAPEUTIC AGENT FOR SLEEP DISORDERS
JP2009516821A (ja) 2005-08-26 2009-04-23 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 試料を扱う及び分析するための基体の材料
WO2007027878A2 (en) 2005-08-31 2007-03-08 Emergent Product Development Gaithersburg Inc. 4-substituted 2-aryloxyphenol derivatives as antibacterial agents
KR20080043840A (ko) 2005-09-13 2008-05-19 팔라우 파르마 에스에이 히스타민 h4 수용체 활성의 조정자로서 2-아미노피리미딘유도체
AR056869A1 (es) 2005-09-13 2007-10-31 Bayer Cropscience Ag Composicion fungicida que comprende un derivado arilamidina y dos compuestos fungicidas conocidos
JP2007084415A (ja) 2005-09-17 2007-04-05 Chikosha:Kk 木材チップを混入した軽量注入材。
WO2007034277A1 (en) 2005-09-19 2007-03-29 Pfizer Products Inc. Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists
JP2007084454A (ja) 2005-09-20 2007-04-05 Fujifilm Corp スルホニウム化合物の製造方法
DE102005045132A1 (de) 2005-09-22 2007-03-29 Archimica Gmbh Verfahren zur Herstellung von 2-Arylcarbonylverbindungen, 2-Arylestern und 2-Arylnitrilen sowie ihrer heteroaromatischen Analoga
GB0519651D0 (en) 2005-09-27 2005-11-02 Univ Nottingham Ferrocenyl phosphite ligands for asymmetric catalysis and a method for their production
EP1960382A1 (en) * 2005-11-03 2008-08-27 ChemBridge Research Laboratories, Inc. Heterocyclic compounds as tyrosine kinase modulators
CN1958568B (zh) 2005-11-03 2011-04-13 中国科学院上海药物研究所 一类预防或治疗幽门螺杆菌感染化合物、其制法和用途
US8017331B2 (en) 2005-11-04 2011-09-13 Mannkind Corporation IRE-1α substrates
EP1957064A4 (en) 2005-11-21 2010-01-06 Tap Pharmaceutical Prod Inc TREATMENT OF QT INTERVAL EXTENSION AND RELEVANT DISEASES
CN101351458A (zh) 2005-12-01 2009-01-21 匹兹堡大学 作为促淀粉样变蛋白成像剂的同位素标记的苯并噻唑化合物
WO2007063522A1 (en) 2005-12-02 2007-06-07 Finorga Sas Process for the preparation of aromatic derivatives of 1-adamantane
DE602006016651D1 (de) 2005-12-02 2010-10-14 Finorga Sas Zwischenprodukte und verfahren zur herstellung aromatischer derivate von 1-adamantan
EP1965764B1 (en) 2005-12-05 2011-07-13 Merck Sharp & Dohme Corp. Self-emulsifying formulations of cetp inhibitors
AR057218A1 (es) 2005-12-15 2007-11-21 Astra Ab Compuestos de oxazolidinona y su uso como pontenciadores del receptor metabotropico de glutamato
TWI403320B (zh) 2005-12-16 2013-08-01 Infinity Discovery Inc 用於抑制bcl蛋白和結合夥伴間之交互作用的化合物及方法
CN101395147B (zh) 2005-12-28 2013-05-29 弗特克斯药品有限公司 作为atp-结合盒转运蛋白调节剂用于治疗囊性纤维化的1-(苯并[d][1,3]间二氧杂环戊烯-5-基)-n-(苯基)环丙烷-甲酰胺衍生物及相关化合物
NZ568904A (en) 2005-12-30 2011-05-27 Merck Sharp & Dohme 1,3-oxazolidin-2-one derivatives useful as CETP inhibitors
WO2007077457A2 (en) 2006-01-06 2007-07-12 The Royal Veterinary College Treatment of equine laminitis with 5-ht1b/ 1d antagonists
KR100814109B1 (ko) 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
GB0601031D0 (en) 2006-01-18 2006-03-01 Novartis Ag Organic compounds
WO2007092930A2 (en) 2006-02-08 2007-08-16 Regents Of The University Of California Method of treatment for mycobacterium tuberculosis
EP1999303A4 (en) * 2006-02-27 2010-09-08 Univ Leland Stanford Junior METHOD FOR IDENTIFYING UPR INHIBITORS
SG136059A1 (en) 2006-03-08 2007-10-29 Nat Inst Immunology 2-thioxothiazolidin-4-one compounds and compositions as antimicrobial and antimalarial agents targeting enoyl-acp reductase of type ii fatty acid synthesis pathway and other cell growth pathways
US20080004282A1 (en) 2006-04-10 2008-01-03 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20070249607A1 (en) 2006-04-17 2007-10-25 Bristol-Myers Squibb Company Nk-1 and serotonin transporter inhibitors
WO2007137107A2 (en) 2006-05-19 2007-11-29 Abbott Laboratories Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
WO2008002246A1 (en) 2006-06-28 2008-01-03 Astrazeneca Ab A pharmaceutical composition comprising an ikk2 inhibitor and a second active ingrdient.
MY157033A (en) 2006-07-11 2016-04-15 Dae Woong Pharma Novel biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same
US7759495B2 (en) 2006-08-11 2010-07-20 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US8329159B2 (en) 2006-08-11 2012-12-11 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7659270B2 (en) 2006-08-11 2010-02-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
EP2420494B1 (en) 2006-08-16 2014-10-08 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Use of thiadiazole compounds as inhibitors of kynurenine-3-monooxygenase
WO2008024963A1 (en) 2006-08-24 2008-02-28 Serenex, Inc. Benzene, pyridine, and pyridazine derivatives
US20080089845A1 (en) 2006-09-07 2008-04-17 N.V. Organon Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
WO2008037266A1 (en) 2006-09-25 2008-04-03 Universite Libre De Bruxelles Inhibitors of conventional protein kinase c isozymes and use thereof for treating inflammatory diseases
WO2008042892A2 (en) 2006-10-02 2008-04-10 N.V. Organon Fatty acid amide hydrolase inhibitors for energy metabolism disorders
EP2520561B1 (en) * 2007-06-08 2016-02-10 MannKind Corporation IRE-1A Inhibitors
JP5127330B2 (ja) 2007-07-12 2013-01-23 日立造船株式会社 光電変換素子およびその製造方法
JP5127335B2 (ja) 2007-07-17 2013-01-23 三井造船株式会社 接続部の構造、バラ積み貨物荷役装置及び接続部の気密保持方法
JP2009149797A (ja) 2007-12-21 2009-07-09 Tohoku Carbon Kk 木炭粉含有塗料組成物及びその塗装方法
USD675543S1 (en) 2011-07-26 2013-02-05 Gizmode, LLC Moisture detection device
JP6135153B2 (ja) 2013-01-30 2017-05-31 井関農機株式会社 管理機

Similar Documents

Publication Publication Date Title
JP2010529147A5 (cg-RX-API-DMAC7.html)
JP2012512863A5 (cg-RX-API-DMAC7.html)
JP2012512907A5 (cg-RX-API-DMAC7.html)
JP2009263394A5 (cg-RX-API-DMAC7.html)
JP2006524660A5 (cg-RX-API-DMAC7.html)
JP2013512277A5 (cg-RX-API-DMAC7.html)
JP2013514367A5 (cg-RX-API-DMAC7.html)
JP2013533253A5 (cg-RX-API-DMAC7.html)
JP2013510123A5 (cg-RX-API-DMAC7.html)
JP2013508279A5 (cg-RX-API-DMAC7.html)
JP2015520140A5 (cg-RX-API-DMAC7.html)
JP2011246469A5 (cg-RX-API-DMAC7.html)
JP2014521744A5 (cg-RX-API-DMAC7.html)
JP2013509392A5 (cg-RX-API-DMAC7.html)
JP2010502730A5 (cg-RX-API-DMAC7.html)
JP2009523760A5 (cg-RX-API-DMAC7.html)
JP2013508413A5 (cg-RX-API-DMAC7.html)
JP2010523476A5 (cg-RX-API-DMAC7.html)
JP2011504903A5 (cg-RX-API-DMAC7.html)
JP2013544276A5 (cg-RX-API-DMAC7.html)
JP2011529502A5 (cg-RX-API-DMAC7.html)
JP2005536503A5 (cg-RX-API-DMAC7.html)
BRPI0517396A (pt) preparação oral com melhor biodisponibilidade
JP2009541387A5 (cg-RX-API-DMAC7.html)
JP2011508779A5 (cg-RX-API-DMAC7.html)